Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: A multicenter cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 2, 2014, Pages e67-e75

  Cornell, Morna ^a   Lessells, Richard ^b,c   Fox, Matthew P ^d,e   Garone, Daniela B ^f   Giddy, Janet ^g   Fenner, Lukas ^h,i   Myer, Landon ^a   Boulle, Andrew ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d BOSTON UNIVERSITY   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f MÉDECINS SANS FRONTIÈRES   (Switzerland)

^g MCCORD HOSPITAL   (South Africa)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Antiretroviral therapy; Lost to follow up; Mortality; Transfers

Indexed keywords

ANTIVIRUS AGENT; ANTIRETROVIRUS AGENT;

ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT TRANSPORT; PRIORITY JOURNAL; SEX DIFFERENCE; SOUTH AFRICA; TRANSFER OUT; ADOLESCENT; AGED; CLINICAL TRIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; INCIDENCE; MIDDLE AGED; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; SOUTH AFRICA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84903361258     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000269     Document Type: Article

References (38)

1. Cornell M, et al. Monitoring the South African national antiretroviral treatment programme, 2003-2007: The IeDEA southern africa collaboration. S Afr Med J. 2009; 99: 653-660.
2. Cornell M, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A multicentre cohort study. Plos Med. 2012; 9: E1001304.
3. Brinkhof MWG, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: Comparison with HIV-unrelated mortality. Plos Med. 2009; 6: E1000066.
4. van Cutsem G, et al. Correcting for mortality among patients lost to follow-up on antiretroviral therapy in South Africa: A cohort analysis. PLoS One. 2011; 6: E14684.
5. Yu J, et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007; 85: 550-554.
6. Chi BH, et al. Universal definition of loss to follow-up in HIV treatment programs: A statistical analysis of 111 facilities in Africa, Asia, and Latin America. Plos Med. 2011; 8: E1001111.
7. Egger M, et al. Correcting mortality for loss to follow-up: A nomogram applied to antiretroviral treatment programs in sub-Saharan Africa. Plos Med. 2011; 8: E1000390.
8. Fenner L, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010; 54: 524-532.
9. Geng EH, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008; 300: 506-507.
10. Cornell M, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010; 24: 2263-2270.
11. Mutevedzi PC, Lessells RJ, Newell M-L, Disengagement from care in a decentralised primary health care antiretroviral treatment programme: Cohort study in rural South Africa. Trop Med Int Health. 2013; n/a-n/a.
12. Nglazi MD, et al. Increasing transfers-out from an antiretroviral treatment service in South Africa: Patient characteristics and rates of virological non-suppression. PLoS One. 2013; 8: E57907.
13. Auld AF, et al. Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program. PLoS One. 2011; 6: E18453.
14. Banda AC, et al. Antiretroviral therapy in the Malawi Defence Force: Access, treatment outcomes and impact on mortality. PLoS One. 2008; 3: E1445.
15. Bussmann H, et al. Five year outcomes of initial patients treated in Botswana's national antiretroviral treatment program. AIDS. 2008; 22: 2303-2311.
16. Wandeler G, et al. Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr. 2012; 59: E9-e16.
17. Rosen S, Fox MP, Gill CJ, Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. Plos Med. 2007; 4: E298.
18. Ekouevi DK, et al. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health. 2010; 15: 34-42.
19. Department of Health, Department of Health Annual report 2009/10, 2010.
20. WHO, UNICEF, and UNAIDS, Global Update on HIV Treatment 2013: Results, Impact and Opportunities. Geneva, Switzerland: WHO, UNICEF, and UNAIDS; 2013.
21. Leonard KL. Active patients in rural African health care: Implications for research and policy. Health Policy Plan. 2013; 1-11.
22. Welaga P, et al. Coming home to die? The association between migration and mortality in rural South Africa. BMC Public Health. 2009; 9: 193.
23. Clark SJ, et al. Returning home to die: Circular labour migration and mortality in South Africa. Scand J Public Health Suppl. 2007; 69: 35-44.
24. Yu JK-L, et al. What happens to patients on antiretroviral therapy who transfer out to another facility? PLoS One. 2008; 3: E2065.
25. Braitstein P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet. 2006; 367: 817-824.
26. Brinkhof M, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programs in lower-income countries. Bull World Health Organ. 2008; 86: 559-567.
27. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: Systematic review. Trop Med Int Health. 2010; 15: 1-15.
28. Harries AD, et al. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010; 15: 70-75.
29. Tweya H, et al. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: The "Back-To-Care" project in Lilongwe, Malawi. Trop Med Int Health. 2010; 15: 82-89.
30. Boyles TH, et al. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011; 6: E19201.
31. Brinkhof MWG, Pujades-Rodriguez M, Egger M, Mortality of patients lost to follow-up in antiretroviral treatment programs in resourcelimited settings: Systematic review and meta-Analysis. PLoS One. 2009; 4: E5790.
32. Long L, et al. Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: An observational cohort. Plos Med. 2011; 8: E1001055.
33. Fatti G, et al. The effect of patient load on antiretroviral treatment programmatic outcomes at primary health care facilities in South Africa: A multicohort study. J Acquir Immune Defic Syndr. 2011; 58: E17-E19.
34. Decroo TMD, et al. Distribution of antiretroviral treatment through selfforming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr. 2011; 56: E39-e44.
35. Jaffar S, et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: A cluster-randomised equivalence trial. Lancet. 2009; 374: 2080-2089.
36. Schomaker M, et al. Non-ignorable loss to follow-up: Correcting mortality estimates based on additional outcome ascertainment. Stat Med. 2013.
37. Little R. In: Fitzmaurice G, et al, eds. Selection and Pattern-mixture Models, in Longitudinal Data Analysis. CRC Press; 2009: 409-432.
38. Department of Health, The National Health Care Facilities Baseline Audit: National Summary Report 2012. Durban, South Africa: 2013.